Janssen BioPharma, Inc. clinical trials
Acquired by Johnson & Johnson, Nov 7, 2014 · source ↗
The registry lists 1 studies whose lead sponsor is Janssen BioPharma, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 29, 2020.
Before and after it joined Johnson & Johnson
- First submitted before Janssen BioPharma, Inc. became part of Johnson & Johnson
- 0
- First submitted after Janssen BioPharma, Inc. became part of Johnson & Johnson
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Janssen BioPharma, Inc.1 study
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Johnson & Johnson studies →
- A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy ParticipantsCompletedNCT03403348Phase 1
Sponsor listed in the registry: Janssen BioPharma, Inc. · First submitted after Janssen BioPharma, Inc. became part of Johnson & Johnson